₹800 for private markets while for the supplies to Union and State governments, Bharat Biotech has kept the price at ₹325. The nasal vaccine for now is not available on CoWin.
"We have achieved the goals we set for ourselves during this pandemic. We have developed COVAXIN® and iNCOVACC®, two COVID vaccines from two different platforms, with two different delivery systems.
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics. We thank the Ministry of Health, CDSCO, Dept of Biotechnology, Govt of India, Technology Development Board, and Washington University, St Louis, for their support and guidance," Dr.
Krishna Ella, Executive Chairman said. On the occasion, other senior delegates of the Union Government will also be present including senior ministers and officials.
iNCOVACC will be the first needleless examination to be given as booster dose. (With inputs from ANI)
.
pandemic
vaccine
Government
Health
platform
Immunic